Tenor Capital Management adds BioPharmX Corp (BPMX
Post# of 223
Posted On: 05/28/2016 12:34:09 PM
Tenor Capital Management adds BioPharmX Corp (BPMX) to its portfolio
May 28, 2016
BioPharmX Corp (BPMX) : Tenor Capital Management added new position in BioPharmX Corp during the most recent quarter end. The investment management firm now holds 63,000 shares of BioPharmX Corp which is valued at $37,800 , the company said in a statement filed on May 13, 2016 with the SEC.BioPharmX Corp makes up approximately 1.48% of Tenor Capital Management’s portfolio.
Other Hedge Funds, Including , Nexthera Capital Lp added BPMX to its portfolio by purchasing 345,440 company shares during the most recent quarter which is valued at $207,264. BioPharmX Corp makes up approx 0.23% of Nexthera Capital Lp’s portfolio.Rtw Investments boosted its stake in BPMX in the latest quarter, The investment management firm added 330,000 additional shares and now holds a total of 700,636 shares of BioPharmX Corp which is valued at $420,382. BioPharmX Corp makes up approx 0.17% of Rtw Investments’s portfolio.Blackrock Fund Advisors boosted its stake in BPMX in the latest quarter, The investment management firm added 308 additional shares and now holds a total of 1,774 shares of BioPharmX Corp which is valued at $1,064.
BioPharmX Corp opened for trading at $0.599 and hit $0.66 on the upside on Wednesday, eventually ending the session at $0.63, with a gain of 5.18% or 0.031 points. The heightened volatility saw the trading volume jump to 16,297 shares. Company has a market cap of $18 M.
Many Wall Street Analysts have commented on BioPharmX Corp. Maxim Group Initiated BioPharmX Corp on Apr 15, 2016 to “Buy”, Price Target of the shares are set at $3.H.C. Wainwright Initiated BioPharmX Corp on Apr 7, 2016 to “Buy”, Price Target of the shares are set at $3.
May 28, 2016
BioPharmX Corp (BPMX) : Tenor Capital Management added new position in BioPharmX Corp during the most recent quarter end. The investment management firm now holds 63,000 shares of BioPharmX Corp which is valued at $37,800 , the company said in a statement filed on May 13, 2016 with the SEC.BioPharmX Corp makes up approximately 1.48% of Tenor Capital Management’s portfolio.
Other Hedge Funds, Including , Nexthera Capital Lp added BPMX to its portfolio by purchasing 345,440 company shares during the most recent quarter which is valued at $207,264. BioPharmX Corp makes up approx 0.23% of Nexthera Capital Lp’s portfolio.Rtw Investments boosted its stake in BPMX in the latest quarter, The investment management firm added 330,000 additional shares and now holds a total of 700,636 shares of BioPharmX Corp which is valued at $420,382. BioPharmX Corp makes up approx 0.17% of Rtw Investments’s portfolio.Blackrock Fund Advisors boosted its stake in BPMX in the latest quarter, The investment management firm added 308 additional shares and now holds a total of 1,774 shares of BioPharmX Corp which is valued at $1,064.
BioPharmX Corp opened for trading at $0.599 and hit $0.66 on the upside on Wednesday, eventually ending the session at $0.63, with a gain of 5.18% or 0.031 points. The heightened volatility saw the trading volume jump to 16,297 shares. Company has a market cap of $18 M.
Many Wall Street Analysts have commented on BioPharmX Corp. Maxim Group Initiated BioPharmX Corp on Apr 15, 2016 to “Buy”, Price Target of the shares are set at $3.H.C. Wainwright Initiated BioPharmX Corp on Apr 7, 2016 to “Buy”, Price Target of the shares are set at $3.
(0)
(0)